These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The amniotic fluid as a source of cells for fetal tissue engineering. Kaviani A; Perry TE; Dzakovic A; Jennings RW; Ziegler MM; Fauza DO J Pediatr Surg; 2001 Nov; 36(11):1662-5. PubMed ID: 11685697 [TBL] [Abstract][Full Text] [Related]
9. A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering. Wang L; Tran I; Seshareddy K; Weiss ML; Detamore MS Tissue Eng Part A; 2009 Aug; 15(8):2259-66. PubMed ID: 19260778 [TBL] [Abstract][Full Text] [Related]
10. Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. Kunisaki SM; Armant M; Kao GS; Stevenson K; Kim H; Fauza DO J Pediatr Surg; 2007 Jun; 42(6):974-9; discussion 979-80. PubMed ID: 17560205 [TBL] [Abstract][Full Text] [Related]
11. Isolation and chondrogenic differentiation of porcine perichondrial progenitor cells for the purpose of cartilage tissue engineering. Derks M; Sturm T; Haverich A; Hilfiker A Cells Tissues Organs; 2013; 198(3):179-89. PubMed ID: 24157487 [TBL] [Abstract][Full Text] [Related]
12. Chondrogenic differentiation of mesenchymal stem cells and its clinical applications. Lee JW; Kim YH; Kim SH; Han SH; Hahn SB Yonsei Med J; 2004 Jun; 45 Suppl():41-7. PubMed ID: 15250049 [TBL] [Abstract][Full Text] [Related]
14. Fetal tracheal augmentation with cartilage engineered from bone marrow-derived mesenchymal progenitor cells. Fuchs JR; Hannouche D; Terada S; Vacanti JP; Fauza DO J Pediatr Surg; 2003 Jun; 38(6):984-7. PubMed ID: 12778408 [TBL] [Abstract][Full Text] [Related]
15. Fiber diameter and seeding density influence chondrogenic differentiation of mesenchymal stem cells seeded on electrospun poly(ε-caprolactone) scaffolds. Bean AC; Tuan RS Biomed Mater; 2015 Jan; 10(1):015018. PubMed ID: 25634427 [TBL] [Abstract][Full Text] [Related]
16. Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model. Moretti M; Wendt D; Dickinson SC; Sims TJ; Hollander AP; Kelly DJ; Prendergast PJ; Heberer M; Martin I Tissue Eng; 2005; 11(9-10):1421-8. PubMed ID: 16259597 [TBL] [Abstract][Full Text] [Related]
17. Expansion of human articular chondrocytes and formation of tissue-engineered cartilage: a step towards exploring a potential use of matrix-induced cell therapy. Munirah S; Samsudin OC; Aminuddin BS; Ruszymah BH Tissue Cell; 2010 Oct; 42(5):282-92. PubMed ID: 20810142 [TBL] [Abstract][Full Text] [Related]
18. Fetal Cartilage-Derived Cells Have Stem Cell Properties and Are a Highly Potent Cell Source for Cartilage Regeneration. Choi WH; Kim HR; Lee SJ; Jeong N; Park SR; Choi BH; Min BH Cell Transplant; 2016; 25(3):449-61. PubMed ID: 26171766 [TBL] [Abstract][Full Text] [Related]
19. Chondrogenic differentiation of mesenchymal stem cells isolated from patients in late adulthood: the optimal conditions of growth factors. Im GI; Jung NH; Tae SK Tissue Eng; 2006 Mar; 12(3):527-36. PubMed ID: 16579686 [TBL] [Abstract][Full Text] [Related]
20. A cartilage ECM-derived 3-D porous acellular matrix scaffold for in vivo cartilage tissue engineering with PKH26-labeled chondrogenic bone marrow-derived mesenchymal stem cells. Yang Q; Peng J; Guo Q; Huang J; Zhang L; Yao J; Yang F; Wang S; Xu W; Wang A; Lu S Biomaterials; 2008 May; 29(15):2378-87. PubMed ID: 18313139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]